Leerink Partners and Oppenheimer & Co. are serving as the joint bookrunning managers for the offering. The Company has granted the underwriters a 45-day option to purchase up to an additional ...
QXO, Inc. (NYSE:QXO) is among the stocks under $50 to buy now. On January 16, Oppenheimer lifted the price target on QXO, Inc ...
Penumbra’s acquisition represents Boston Scientific’s second-largest takeover in its history and marks its re-entry into the neurovascular market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback